Deutsche Bank’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,332
| Closed | -$25K | – | 4255 |
|
|
2022
Q1 | $25K | Buy |
1,332
+621
| +87% | +$11.7K | ﹤0.01% | 3895 |
|
|
2021
Q4 | $25K | Sell |
711
-751
| -51% | -$26.4K | ﹤0.01% | 3952 |
|
|
2021
Q3 | $107K | Buy |
1,462
+1,100
| +304% | +$80.5K | ﹤0.01% | 3815 |
|
|
2021
Q2 | $51K | Sell |
362
-850
| -70% | -$120K | ﹤0.01% | 4171 |
|
|
2021
Q1 | $352K | Buy |
+1,212
| New | +$352K | ﹤0.01% | 3304 |
|